Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip H. Elsinga

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PETDavid C P Cobben, Bernard F A M van der Laan, Bram Maas, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2017
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET ImagingRenske M Raaphorst, Heli Savolainen, Mariangela Cantore, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Development of <sup>89</sup>Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltrationArjan Kol, Xiaoyu Fan, Marta A Wazynska, et al.
EJNMMI Radiopharmacy and Chemistry|October 6, 2022
A closer look at the synthesis of 2-[<sup>18</sup>F]fluoroethyl tosylate to minimize the formation of volatile side-productsMartha Sahylí Ortega Pijeira, Sofia Nascimento Dos Santos, Yasniel Babi Araujo, et al.
Critical Reviews in Oncology/Hematology|June 28, 2011
Tailored imaging of islet cell tumors of the pancreas amidst increasing optionsHelle-Brit Fiebrich, Sophie J van Asselt, Adrienne H Brouwers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent modelAren van Waarde, David C P Cobben, Albert J H Suurmeijer, et al.
Nuclear Medicine and Biology|August 16, 2024
Synthesis and preclinical evaluation of [<sup>18</sup>F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophagesBruna Fernandes, Ines F Antunes, Kavya Prasad, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Journal of Medicinal Chemistry|July 26, 2014
Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomographyShivashankar Khanapur, Soumen Paul, Anup Shah, et al.
International Journal of Molecular Imaging|January 23, 2015
Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 ReceptorsJan-Peter van Wieringen, Kora de Bruin, Henk M Janssen, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PETDavid C P Cobben, Bernard F A M van der Laan, Bram Maas, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2017
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET ImagingRenske M Raaphorst, Heli Savolainen, Mariangela Cantore, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Development of <sup>89</sup>Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltrationArjan Kol, Xiaoyu Fan, Marta A Wazynska, et al.
EJNMMI Radiopharmacy and Chemistry|October 6, 2022
A closer look at the synthesis of 2-[<sup>18</sup>F]fluoroethyl tosylate to minimize the formation of volatile side-productsMartha Sahylí Ortega Pijeira, Sofia Nascimento Dos Santos, Yasniel Babi Araujo, et al.
Critical Reviews in Oncology/Hematology|June 28, 2011
Tailored imaging of islet cell tumors of the pancreas amidst increasing optionsHelle-Brit Fiebrich, Sophie J van Asselt, Adrienne H Brouwers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent modelAren van Waarde, David C P Cobben, Albert J H Suurmeijer, et al.
Nuclear Medicine and Biology|August 16, 2024
Synthesis and preclinical evaluation of [<sup>18</sup>F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophagesBruna Fernandes, Ines F Antunes, Kavya Prasad, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup> C]TelmisartanSjoukje van der Hoek, Douwe J Mulder, Antoon T M Willemsen, et al.
Journal of Medicinal Chemistry|July 26, 2014
Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomographyShivashankar Khanapur, Soumen Paul, Anup Shah, et al.
International Journal of Molecular Imaging|January 23, 2015
Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 ReceptorsJan-Peter van Wieringen, Kora de Bruin, Henk M Janssen, et al.
Pageof 17